Kangmei Pharma | 600518 - Current Assets

Stock Price
1.87
Daily Change
-0.01 -0.53%
Monthly
-2.09%
Yearly
-16.14%
Q1 Forecast
1.84

Kangmei Pharma reported CNY7.03B in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
Akebia Therapeutics USD 252.96M 5.38M Dec/2025
Alaunos Therapeutics USD 2.68M 1.05M Sep/2025
Avita Medical AUD 35.49M 760K Dec/2025
Cspc Pharmaceutical CNY 22.61B 721.94M Jun/2025
Dianthus Therapeutics USD 409.44M 4.39M Dec/2025
Genomma Lab Internacional MXN 12.84B 17.52M Dec/2025
Hypermarcas BRL 6.29B 675.28M Sep/2025
Ionis Pharmaceuticals USD 2.99B 471.01M Dec/2025
IQVIA Holdings USD 6.25B 270M Dec/2025
Jiangsu Hengrui CNY 51.4B 4.64B Sep/2025
Kangmei Pharma CNY 7.03B 128.34M Sep/2025
Moderna USD 6.54B 54M Dec/2025
Organon & Co USD 4.7B 82M Sep/2025
Revvity USD 2.24B 95.96M Dec/2025
Sh Fosun Pharma CNY 32.15B 2.2B Sep/2025
Tectonic Therapeutic USD 273.24M 17.61M Sep/2025
Viatris USD 9.79B 162.2M Dec/2025
Wuxi Apptec CNY 53.81B 11.22B Sep/2025
Xeris Pharmaceuticals USD 224.02M 38.44M Sep/2025
Zz Pientze Pharmaceu CNY 10.7B 1.59B Sep/2025